Trends in innovation for enhanced gene therapy downstream process intensification and product yield

The gene therapy industry has a pressing need for advancements in the downstream processing of viral vectors to better accommodate more complex and fragile advanced therapy medicinal products. Particularly with AAVs, downstream processing is crucial to ensure high yield and purity of the final product. This infographic highlights the steps and challenges associated with downstream processing, emphasizing the importance of novel innovations and process developments.

Please enter your email to access content Read now